ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT FEBRUARY 2025

News provided by

05 Mar, 2025, 08:21 GMT

Zinzino group revenue increased with a total of 48%, compared with the previous year.

GOTHENBURG, Sweden, March 5, 2025 /PRNewswire/ -- The revenue in February for Zinzino's sales markets increased by 56% and amounted to SEK 212.7 (136.4) million. Faun Pharma's external sales decreased and amounted to SEK 4.2 (9.7) million. Overall, the Group increased revenues by 48% to SEK 216.9 (146.1) million compared with the previous year.

Accumulated revenue for January – February 2025 increased by 53% to SEK 450.8 (295.0) million.

Revenues were distributed as follows:

Regions, MSEK	25-Feb	24-Feb	Change	YTD 2025	YTD 2024	Change
The Nordics	24.8	22.4	11 %	50.4	45.0	12 %
Central Europe	58.1	36.8	58 %	127.4	77.8	64 %
East Europe	29.0	30.1	-4 %	63.4	62.0	2 %
South & West Europe	37.9	23.0	65 %	82.5	45.0	83 %
The Baltics	8.9	8.0	11 %	19.4	16.0	21 %
North America	32.6	11.6	181 %	55.0	21.9	151 %
Asia-Pacific	19.9	3.4	485 %	40.7	7.4	450 %
Africa	1.5	1.1	36 %	3.0	2.1	43 %
Zinzino	212.7	136.4	56 %	441.8	277.2	59 %
Faun Pharma	4.2	9.7	11 %	9.0	17.8	-49 %
Zinzino Group	216.9	146.1	48 %	450.8	295.0	53 %

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa